Preview
This chapter discusses the challenges faced by Saint Louis University (SLU) professor William S.M. Mold in the commercialization of his cancer research. It explains that Mold is the president and CEO of a biotechnology company he founded called VirRx and SLU was uneasy about the propriety of the complex financial arrangements for Wold's research. The SLU's Conflict of Interest Committee deliberated on the issue and decided to move VirRx laboratory to an off-campus location in order to have clear distinction between university business and private business.
Keywords: William S.M. Mold; SLU; cancer research; VirRx; financial arrangements; conflict of interest; university business; private business
Chapter. 5750 words.
Subjects: Ethical Issues and Debates
Go to University Press Scholarship Online » abstract
Full text: subscription required
How to subscribe Recommend to my Librarian
Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.
